We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Endometrial Scratching Use Declining, But Still Popular

By HospiMedica International staff writers
Posted on 10 Jan 2022
A new survey finds that one-third of fertility specialists still offer endometrial scratching as an adjunct to in vitro fertilization (IVF), despite lack of evidence that it increases conception rates.

Researchers at the University of Melbourne (UNIMELB; Melbourne, Australia), and Monash University (Melbourne, Australia) undertook an online survey among fertility healthcare personnel to ascertain current practices and views regarding endometrial scratching across Australia, New Zealand, and the United Kingdom. More...
In all, 121 eligible responses were received between October and December 2020, which included 61 fertility specialists, 26 embryologists, and 24 fertility nurses.

The results showed most of the respondents were neutral or did not believe endometrial scratching improved pregnancy and live birth rates, except for in women with recurrent implantation failure. In addition, 55% viewed reducing psychological distress as a benefit of endometrial scratching. Among fertility specialists, 34% still offer endometrial scratching, mostly following recurrent implantation failure. Among fertility specialists not offering endometrial scratching, 51% previously offered it, but no longer do. The survey was published on December 14, 2021, in Human Fertility.

“The use of endometrial scratching appears to have reduced over time, probably following recent publications of studies which do not report that the procedure improves the chance of having a baby,” concluded lead author embryologist Madina Sarwari, MSc, of Monash University, and colleagues. “This is an encouraging finding, as it's clear that many IVF providers do respond to new evidence as it emerges.”

Endometrial scratching is a common IVF add-on procedure using a Pipelle endometrial biopsy device, or similar. It has been suggested that the biopsy induces endometrial inflammation, which in turn increases endometrial receptivity and facilitates implantation. The decline in use evidenced over the last five years follows several large trials that showed no clear evidence for improved live birth rates following endometrial scratching before IVF.

Related Links:
University of Melbourne
Monash University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.